ATE287393T1 - Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung - Google Patents

Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung

Info

Publication number
ATE287393T1
ATE287393T1 AT99907879T AT99907879T ATE287393T1 AT E287393 T1 ATE287393 T1 AT E287393T1 AT 99907879 T AT99907879 T AT 99907879T AT 99907879 T AT99907879 T AT 99907879T AT E287393 T1 ATE287393 T1 AT E287393T1
Authority
AT
Austria
Prior art keywords
substituents
hydrocarbon group
group optionally
aliphatic hydrocarbon
hydrogen atom
Prior art date
Application number
AT99907879T
Other languages
English (en)
Inventor
Yuzo Ichimori
Masayuki Ii
Katsumi Itoh
Tomoyuki Kitazaki
Junji Yamada
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE287393T1 publication Critical patent/ATE287393T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/14—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
AT99907879T 1998-03-09 1999-03-08 Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung ATE287393T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP5649298 1998-03-09
JP28436298 1998-10-06
PCT/JP1999/001103 WO1999046242A1 (fr) 1998-03-09 1999-03-08 Derives de cycloalcene, leur procede de fabrication et d'utilisation

Publications (1)

Publication Number Publication Date
ATE287393T1 true ATE287393T1 (de) 2005-02-15

Family

ID=26397446

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99907879T ATE287393T1 (de) 1998-03-09 1999-03-08 Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung

Country Status (20)

Country Link
US (1) US6495604B1 (de)
EP (2) EP1063228B1 (de)
JP (2) JP3665712B2 (de)
KR (4) KR100492098B1 (de)
CN (1) CN100432049C (de)
AT (1) ATE287393T1 (de)
AU (1) AU747521B2 (de)
BR (1) BR9908610A (de)
CA (1) CA2320467C (de)
DE (1) DE69923300T2 (de)
DK (1) DK1063228T5 (de)
ES (1) ES2232114T3 (de)
HK (1) HK1031723A1 (de)
HU (1) HU230061B1 (de)
ID (1) ID25649A (de)
NO (1) NO326426B1 (de)
NZ (1) NZ505874A (de)
PT (1) PT1063228E (de)
RU (1) RU2214398C2 (de)
WO (1) WO1999046242A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3665712B2 (ja) 1998-03-09 2005-06-29 武田薬品工業株式会社 シクロアルケン誘導体、その製造法および用途
US20040220103A1 (en) * 1999-04-19 2004-11-04 Immunex Corporation Soluble tumor necrosis factor receptor treatment of medical disorders
ATE482930T1 (de) * 1999-08-06 2010-10-15 Takeda Pharmaceutical Substituierte aromatische ringverbindungen, verfahren zu ihrer herstellung und ihre anwendung
WO2001040498A1 (fr) * 1999-11-29 2001-06-07 Takeda Chemical Industries, Ltd. Procede de production de derives optiquement actifs du cyclohexene et de leurs intermediaires
US7105572B2 (en) 2000-02-04 2006-09-12 Takeda Pharmaceutical Company Limited Stable emulsion compositions
JP4863553B2 (ja) * 2000-02-04 2012-01-25 武田薬品工業株式会社 安定な乳化組成物
JP4922507B2 (ja) * 2000-08-10 2012-04-25 武田薬品工業株式会社 医薬組成物
AU2001278705A1 (en) * 2000-08-10 2002-02-25 Takeda Chemical Industries Ltd. Pharmaceutical composition
ATE508109T1 (de) 2000-10-18 2011-05-15 Takeda Pharmaceutical Verfahren zur herstellung von optisch aktiven sulfonamiden und zwischenprodukte zur deren synthese
WO2002045750A1 (fr) * 2000-12-08 2002-06-13 Takeda Chemical Industries, Ltd. Medicaments combines
US7579325B2 (en) 2001-03-21 2009-08-25 Eisai R & D Management Co., Ltd. Drugs containing reduced of vitamin B2
EP1420783A4 (de) * 2001-08-03 2009-09-30 Takeda Pharmaceutical Stabile emulsionszusammensetzung
EP1495756A4 (de) * 2002-04-08 2009-10-28 Takeda Pharmaceutical Therapeutikum zur prävention schwerer sepsis
CA2547410C (en) * 2003-12-03 2013-07-30 Boehringer Ingelheim Pharmaceuticals, Inc. 1,2,3-triazole amide derivatives as inhibitors of cytokie production
MY147790A (en) * 2005-04-28 2013-01-31 Takeda Pharmaceutical Stable emulsion composition
RU2386613C2 (ru) 2005-09-14 2010-04-20 Дайити Санкио Компани, Лимитед Замещенные циклоалкеновые производные
JP4962982B2 (ja) 2006-03-30 2012-06-27 国立大学法人広島大学 スクリーニング方法
CA2649628A1 (en) 2006-04-20 2007-11-01 Takeda Pharmaceutical Company Limited Pharmaceutical product
US20090105314A1 (en) * 2006-05-15 2009-04-23 Takeda Pharmaceutical Company Limited Pharmaceutical Agent
JPWO2008004673A1 (ja) * 2006-07-07 2009-12-10 武田薬品工業株式会社 シクロアルケン誘導体、その製造法および用途
JP2008260760A (ja) * 2007-03-12 2008-10-30 Daiichi Sankyo Co Ltd 置換シクロアルケン誘導体を含有する医薬組成物
JP6131046B2 (ja) 2010-01-27 2017-05-17 武田薬品工業株式会社 抗癌剤により誘発される末梢神経障害を抑制する化合物
WO2012039447A1 (ja) 2010-09-24 2012-03-29 第一三共株式会社 置換シクロアルケン誘導体の結晶
JP6509112B2 (ja) * 2012-07-03 2019-05-08 プラブダ，ジェイ オキソ関連状態の治療、診断および／またはその進行のモニタリングのための方法
WO2014050910A1 (ja) 2012-09-26 2014-04-03 武田薬品工業株式会社 固体粒子の製造方法
AR104539A1 (es) 2015-05-08 2017-07-26 Takeda Pharmaceuticals Co Compuestos cíclicos
JP7029400B2 (ja) 2016-09-09 2022-03-03 武田薬品工業株式会社 環状化合物
CN110352189A (zh) * 2017-02-24 2019-10-18 景凯生物科技股份有限公司 用于预防及/或治疗自体免疫、发炎或感染相关障碍的磺酰胺或酰胺化合物、组合物与方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU217808B (hu) 1990-11-06 2000-04-28 Nippon Shinyaku Co., Ltd. Eljárás liofilizált készítmény előállítására
US5576016A (en) 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
WO1995022973A1 (en) 1994-02-25 1995-08-31 Takeda Chemicals Industries, Ltd. Injectable emulsions containing antifungal triazole derivatives
EP0776886A4 (de) * 1994-08-18 1999-05-12 Chugai Pharmaceutical Co Ltd Aminosäurenderivat mit stickstoffmonoxidsynthetase inhibierender aktivität
JPH08109165A (ja) * 1994-08-18 1996-04-30 Chugai Pharmaceut Co Ltd 一酸化窒素合成酵素阻害作用を有するアミノ酸誘導体
JP3665712B2 (ja) 1998-03-09 2005-06-29 武田薬品工業株式会社 シクロアルケン誘導体、その製造法および用途
US7105572B2 (en) 2000-02-04 2006-09-12 Takeda Pharmaceutical Company Limited Stable emulsion compositions

Also Published As

Publication number Publication date
JP2000178246A (ja) 2000-06-27
BR9908610A (pt) 2000-12-05
CN100432049C (zh) 2008-11-12
PT1063228E (pt) 2005-05-31
HUP0101192A2 (hu) 2001-08-28
KR100779889B1 (ko) 2007-11-28
NZ505874A (en) 2003-09-26
US6495604B1 (en) 2002-12-17
NO20004485D0 (no) 2000-09-08
DE69923300T2 (de) 2006-01-05
EP1524263A1 (de) 2005-04-20
JP2005232168A (ja) 2005-09-02
DE69923300D1 (de) 2005-02-24
JP4342453B2 (ja) 2009-10-14
ES2232114T3 (es) 2005-05-16
EP1063228B1 (de) 2005-01-19
KR20050026075A (ko) 2005-03-14
AU747521C (en) 1999-09-27
CA2320467A1 (en) 1999-09-16
AU2746499A (en) 1999-09-27
WO1999046242A1 (fr) 1999-09-16
NO326426B1 (no) 2008-12-01
CA2320467C (en) 2010-05-04
KR20010034555A (ko) 2001-04-25
KR100492098B1 (ko) 2005-06-01
CN1291184A (zh) 2001-04-11
AU747521B2 (en) 2002-05-16
KR20050071719A (ko) 2005-07-07
HUP0101192A3 (en) 2003-09-29
RU2214398C2 (ru) 2003-10-20
NO20004485L (no) 2000-09-08
KR20060017921A (ko) 2006-02-27
EP1063228A1 (de) 2000-12-27
ID25649A (id) 2000-10-19
HK1031723A1 (en) 2001-06-22
DK1063228T3 (da) 2005-04-25
HU230061B1 (hu) 2015-06-29
JP3665712B2 (ja) 2005-06-29
DK1063228T5 (da) 2009-06-15
EP1063228A4 (de) 2001-08-08
KR100577044B1 (ko) 2006-05-08
PL342826A1 (en) 2001-07-02

Similar Documents

Publication Publication Date Title
ATE287393T1 (de) Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung
DE69726309D1 (de) Zuckerderivate, geliermittel, geliermittelzubereitungen, verfahren zu ihrer herstellung und gelzubereitungen
DE60137426D1 (de) 1,2-dihydropyridinverbindungen, verfahren zu deren herstellung und deren verwendung
DE69835877D1 (de) Trizyklische verbindungen
DE69524251D1 (de) Neue verbindung, verfahren zu ihrer herstellung und antitumormittel
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE164582T1 (de) 1-methylcarbapenemderivate und verfahren zu ihrer herstellung
DE3576955D1 (de) Beta-carbolin-3-oxadiazolylderivate, verfahren zu ihrer herstellung und ihre verwendung.
ATE482930T1 (de) Substituierte aromatische ringverbindungen, verfahren zu ihrer herstellung und ihre anwendung
ATE240949T1 (de) Epoxysuccinamid-derivate oder ihre salze
DE60002558D1 (de) Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B
ATE143354T1 (de) N-alkoxymethylbenzamid-derivate und verfahren zu ihrer herstellung und ihre verwendung zur herstellung von benzamid-derivaten
ATE179972T1 (de) Pyridazinone-derivate und verfahren zur deren herstellung
DE69425970T2 (de) Benzol-derivate, verwendbar für ischämische erkrankungen
ATE250597T1 (de) N-benzolsulfonyl-l-prolin derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DK0556813T3 (da) Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler
ATE261441T1 (de) Analoga von distamycin-zimtsäurederivaten, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
DE69818051D1 (de) N-benzenesulfonyl-l-prolin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
EP0798304A4 (de) Medikamente gegen trhombocytopenie
ATE139767T1 (de) Verfahren zur herstellung 5-pyrazolomerkaptan- derivate und dessen zwischenprodukte
ATE117689T1 (de) Verfahren zur herstellung von lactamderivaten.
TH23733A (th) สารประกอบคาร์โบไซคลิค

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1063228

Country of ref document: EP